Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GAA | P10253 | 1/20 | 0.39 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.38 |
| ▸ | RAPGEF3 | O95398 | 7/20 | 0.36 |
| ▸ | RAPGEF4 | Q8WZA2 | 5/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.34 |
| ▸ | PKM | P14618 | 1/20 | 0.34 |
| ▸ | SHMT1 | P34896 | 1/20 | 0.34 |
| ▸ | AHR | P35869 | 1/20 | 0.33 |
| ▸ | NOTUM | Q6P988 | 1/20 | 0.32 |
| ▸ | KIF11 | P52732 | 1/20 | 0.32 |
| ▸ | GPBAR1 | Q8TDU6 | 1/20 | 0.32 |
| ▸ | DDR1 | Q08345 | 2/20 | 0.31 |
| ▸ | SLC13A3 | Q8WWT9 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10913469 | 0.75 | RAPGEF4 (0.39) | GAAL3MBTL1RAPGEF4ALDH1A1AHR | |
| SCHEMBL1008766 | 0.74 | RAPGEF3 (0.40) | GAAL3MBTL1RAPGEF3RAPGEF4ALDH1A1 | |
| SCHEMBL628010 | 0.73 | KIF11 (0.44) | RAPGEF3RAPGEF4AHRKIF11DDR1 | |
| SCHEMBL9967739 | 0.73 | RAPGEF4 (0.41) | L3MBTL1RAPGEF4ALDH1A1AHRNOTUM | |
| SCHEMBL5188795 | 0.73 | PNMT (0.49) | GAA | |
| SCHEMBL28944233 | 0.72 | SLC13A3 (0.38) | AHRDDR1SLC13A3 | |
| Nitrogen SCHEMBL9592328 | 0.71 | AHR (0.48) | GAAL3MBTL1RAPGEF4ALDH1A1AHR | |
| SCHEMBL195126 | 0.71 | KIF11 (0.45) | L3MBTL1ALDH1A1PKMKIF11 | |
| SCHEMBL321756 | 0.71 | AHR (0.52) | GAAL3MBTL1RAPGEF4ALDH1A1AHR | |
| SCHEMBL3786224 | 0.71 | RAPGEF4 (0.47) | RAPGEF4ALDH1A1AHRNOTUMSLC13A3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6528657-B2 | For use in electroluminescence light emission element and can emit lights of various colors when an energy such as electric energy or electromagnetic energy is applied thereto | TAIHO INDUSTRIES CO., LTD. (JP) | 2003-03-04 | — | — | US | disclosed |
| US-20030023099-A1 | Novel fluorescent carbazole derivative | HIROSE ENGINEERING CO., LTD. (JP) | 2003-01-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030023099-A1 | Novel fluorescent carbazole derivative | CBR3, AANAT, SIRT3 | GAA 3940/4885L3MBTL1 1222/4885RAPGEF3 1645/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.